GSK Pharma to pay Rs 28/shr, FY05 group net up 50%

GlaxoSmithKline Pharmaceuticals (GSK Pharma) today reported a 50% increase in consolidated net profit at Rs 507.14 crore for the year ended December 31, 2005 when compared with Rs 337.67 crore in FY04.

According to a release issued by the company to the BSE today, total income increased to Rs 1,584.60 crore in FY05 from Rs 1,462.97 crore in FY04.

The board has recommended a dividend of Rs 14 per share for the year ended December 31, 2005. "The directors also recommended a special, additional one-time dividend of Rs 14 per share," the release added.

The register of members & share transfer book of the company will remain closed from March 28, 2006 to April 12, 2006 (both days inclusive) for the payment of Dividend. The dividend will be payable on or after April 12, 2006, the release said.

The company, on a stand-alone basis, posted a net profit of Rs 42.38 crore for the fourth quarter ended December 31, 2005 as against Rs 23.63 crore in Q4FY04. Total income increased to Rs 344.39 crore in Q4FY05 from Rs 299.24 crore in Q4FY04.

The company reported a net profit of Rs 502.08 crore for the year ended December 31, 2005 when compared with Rs 333.09 crore in FY04. Total income increased to Rs 1,550.94 crore in FY05 from Rs 1,429.23 crore in FY04.